Cargando…

TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression

Tumor necrosis factor alpha-induced protein 8 (TNFAIP8) is implicated in the tumor progression and prognosis of triple-negative breast cancer (TNBC), but the detailed regulatory mechanism of TNFAIP8 in cisplatin tolerance in TNBC has not yet been investigated. TNFAIP8 was evidently upregulated in TN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Hong-Yu, Li, Yang, Yin, Hui-Zi, Yin, Hang, Qu, Yuan-Yuan, Xu, Qing-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581818/ https://www.ncbi.nlm.nih.gov/pubmed/33230463 http://dx.doi.org/10.1016/j.omtn.2020.09.025

Ejemplares similares

Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
por: Ma, Hong-Yu, et al.
Publicado: (2023)

TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway
por: Xing, Ying, et al.
Publicado: (2018)

LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway
por: Li, Yang, et al.
Publicado: (2020)

Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness
por: Siemens, Helge, et al.
Publicado: (2013)

MicroRNA-205-5p targets the HOXD9-Snail1 axis to inhibit triple negative breast cancer cell proliferation and chemoresistance
por: Lin, Li-Fen, et al.
Publicado: (2021)

A p53/lnc‐Ip53 Negative Feedback Loop Regulates Tumor Growth and Chemoresistance
por: Zhang, Li‐Zhen, et al.
Publicado: (2020)

Long noncoding RNA DLEU2 drives the malignant behaviors of thyroid cancer through mediating the miR-205-5p/TNFAIP8 axis
por: Yang, Jiwen, et al.
Publicado: (2021)

Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer
por: Kamoshida, S, et al.
Publicado: (2007)

MicroRNA-504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53
por: Chen, Xin, et al.
Publicado: (2019)

miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors
por: Jacques, Camille, et al.
Publicado: (2016)

Upregulated GATA3/miR205-5p Axis Inhibits MFNG Transcription and Reduces the Malignancy of Triple-Negative Breast Cancer
por: Mugisha, Samson, et al.
Publicado: (2022)

miR-1205/DNAJB1 reverses docetaxel chemoresistance in human triple negative breast carcinoma cells via regulation of mutp53/TAp63 signaling: miR-1205/DNAJB1 reverses docetaxel chemoresistance in TNBC
por: Yin, Yongxiang, et al.
Publicado: (2021)

RETRACTED ARTICLE: MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8
por: Ge, Xinhong, et al.
Publicado: (2021)

Retraction Note: MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8
por: Ge, Xinhong, et al.
Publicado: (2022)

BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell
por: Chen, Ming-Kun, et al.
Publicado: (2021)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
por: Pan, Yunbao, et al.
Publicado: (2017)

Suppression of cell growth and invasion by miR-205 in breast cancer
por: Wu, Hailong, et al.
Publicado: (2009)

MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance
por: Lai, Xin, et al.
Publicado: (2018)

miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer
por: Li, Hao-Yi, et al.
Publicado: (2017)

TIPE1 Promotes Cervical Cancer Cell Chemoresistance to Cisplatin in a Wild-Type p53-Dependent Manner
por: Jiang, Jie, et al.
Publicado: (2021)

Synergistic anticancer effect of combined crocetin and cisplatin on KYSE-150 cells via p53/p21 pathway
por: Li, Sheng, et al.
Publicado: (2017)

miR-205 and miR-200c: Predictive Micro RNAs for Lymph Node Metastasis in Triple Negative Breast Cancer
por: Berber, Ufuk, et al.
Publicado: (2014)

MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2
por: Zhao, Henan, et al.
Publicado: (2016)

Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Association of Loss of Heterozygosity at the p53 Locus with Chemoresistance in Osteosarcomas
por: Goto, Akiteru, et al.
Publicado: (1998)

p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance
por: Souza, Leonel Cardozo de Menezes e, et al.
Publicado: (2022)

The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene
por: Pu, Youguang, et al.
Publicado: (2017)

p53-Dependent Repression: DREAM or Reality?
por: Peuget, Sylvain, et al.
Publicado: (2021)

miR-205-5p Mediated Downregulation of PTEN Contributes to Cisplatin Resistance in C13K Human Ovarian Cancer Cells
por: Shi, Xiaoyan, et al.
Publicado: (2018)

Oxidative stress‐induced angiogenesis is mediated by miR‐205‐5p
por: Oltra, Maria, et al.
Publicado: (2019)

The fate of chemoresistance in triple negative breast cancer (TNBC)
por: O’Reilly, Elma A., et al.
Publicado: (2015)

Exosome‐mediated delivery of miR‐204‐5p inhibits tumor growth and chemoresistance
por: Yao, Surui, et al.
Publicado: (2020)

Inhibition of retinoic acid receptor α phosphorylation represses the progression of triple-negative breast cancer via transactivating miR-3074-5p to target DHRS3
por: Lou, Siyue, et al.
Publicado: (2021)

Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
por: Zhang, Kun, et al.
Publicado: (2020)

Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance
por: Robinson, Prema, et al.
Publicado: (2016)

The prognostic relevance of p53 and Ki-67 to chemotherapy sensitivity and prognosis in triple-negative breast cancer
por: Zhang, Guojing, et al.
Publicado: (2021)

PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation
por: Kobayashi, Noriko, et al.
Publicado: (2013)

The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation
por: Wang, Hao, et al.
Publicado: (2018)

miR-205-5p inhibits homocysteine-induced pulmonary microvascular endothelium dysfunction by targeting FOXO1: miR-205-5p inhibits pulmonary microvascular endothelial dysfunction
por: Huang, Xiaobo, et al.
Publicado: (2023)

A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness
por: di Gennaro, Alessandra, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3nuh3aei7jd02t1ddoe3bachko